Table 3

Factors Associated with PSA Screening Intensity,a 2010 National Health Interview Survey

FactorLow Intensity vs No Screeninga
OR (95% CI)b
High Intensity vs No Screening
OR (95% CI)b
P Valuec
Age, year<.001
 50–591.01.0
 60–691.41 (1.07–1.86)2.95 (2.12–4.11)
 70–741.54 (0.90–2.65)4.59 (2.68–7.87)
Education.002
 <High school graduate1.01.0
 High school graduate1.37 (0.90–2.08)1.56 (0.84–2.89)
 Some college/technical institute1.00 (0.64–1.56)1.68 (0.95–2.96)
 College graduate1.58 (0.97–2.57)2.92 (1.55–5.49)
Usual source of medical care<.001
 Yes1.01.0
 No0.46 (0.29–0.74)0.15 (0.06–0.38)
Doctor recommendation<.001
 Yes44.10 (31.68–61.41)107.37 (71.42–161.41)
 No1.01.0
Extent of shared decision makingd<.001
 No elements1.01.0
 Partial, disadvantages only, disadvantages and uncertainty, or uncertainty only3.84 (1.24–11.91)4.87 (1.48–16.02)
 Partial, advantages only2.38 (1.53–3.71)3.22 (1.94–5.35)
 Partial, advantages and disadvantages or advantages and uncertainty3.97 (1.82–8.68)3.82 (1.67–8.69)
 All elements1.98 (0.97–4.04)1.96 (0.93–4.11)
  • a PSA Screening intensity: “no screening” = no prior testing; “low intensity” = 1–3 tests/past 5 years; “high intensity” = 4–5 tests/past 5 years

  • b Confidence interval from multivariable polytomous logistic regression model with PSA screening as the dependent variable (n = 3,209); analyses adjusted for race, ethnicity, poverty ratio, self-reported health status, number of chronic diseases, personal history of cancer, family history of prostate cancer, health insurance.

  • c P value for Wald χ2 test for association.

  • d Physician discussion of the following elements: advantages, disadvantages, and uncertainty.